Page last updated: 2024-10-27

fenofibrate and Pulmonary Fibrosis

fenofibrate has been researched along with Pulmonary Fibrosis in 1 studies

Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE

Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.

Research Excerpts

ExcerptRelevanceReference
"Idiopathic pulmonary fibrosis is the most prevalent chronic fibrosing lung disease."5.38Evaluation of the antifibrotic effect of fenofibrate and rosiglitazone on bleomycin-induced pulmonary fibrosis in rats. ( El-Aidy, Ael-R; Ewais, MM; Samah, M; Tawfik, MK, 2012)
"Idiopathic pulmonary fibrosis is the most prevalent chronic fibrosing lung disease."1.38Evaluation of the antifibrotic effect of fenofibrate and rosiglitazone on bleomycin-induced pulmonary fibrosis in rats. ( El-Aidy, Ael-R; Ewais, MM; Samah, M; Tawfik, MK, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Samah, M1
El-Aidy, Ael-R1
Tawfik, MK1
Ewais, MM1

Other Studies

1 other study available for fenofibrate and Pulmonary Fibrosis

ArticleYear
Evaluation of the antifibrotic effect of fenofibrate and rosiglitazone on bleomycin-induced pulmonary fibrosis in rats.
    European journal of pharmacology, 2012, Aug-15, Volume: 689, Issue:1-3

    Topics: Animals; Antifibrinolytic Agents; Bleomycin; Drug Evaluation, Preclinical; Drug Therapy, Combination

2012